| Literature DB >> 33859554 |
Monika Klírová1,2, Veronika Voráčková1,2, Jiří Horáček1,2, Pavel Mohr1,2, Juraj Jonáš1, Daniela Urbaczka Dudysová1,2, Lenka Kostýlková1,2, Dan Fayette1,2, Lucie Krejčová1, Silvie Baumann1, Olga Laskov1,2, Tomáš Novák1,2.
Abstract
Increased frontal midline theta activity generated by the anterior cingulate cortex (ACC) is induced by conflict processing in the medial frontal cortex (MFC). There is evidence that theta band transcranial alternating current stimulation (θ-tACS) modulates ACC function and alters inhibitory control performance during neuromodulation. Multi-electric (256 electrodes) high definition θ-tACS (HD θ-tACS) using computational modeling based on individual MRI allows precise neuromodulation targeting of the ACC via the medial prefrontal cortex (mPFC), and optimizes the required current density with a minimum impact on the rest of the brain. We therefore tested whether the individualized electrode montage of HD θ-tACS with the current flow targeted to the mPFC-ACC compared with a fixed montage (non-individualized) induces a higher post-modulatory effect on inhibitory control. Twenty healthy subjects were randomly assigned to a sequence of three HD θ-tACS conditions (individualized mPFC-ACC targeting; non-individualized MFC targeting; and a sham) in a double-blind cross-over study. Changes in the Visual Simon Task, Stop Signal Task, CPT III, and Stroop test were assessed before and after each session. Compared with non-individualized θ-tACS, the individualized HD θ-tACS significantly increased the number of interference words and the interference score in the Stroop test. The changes in the non-verbal cognitive tests did not induce a parallel effect. This is the first study to examine the influence of individualized HD θ-tACS targeted to the ACC on inhibitory control performance. The proposed algorithm represents a well-tolerated method that helps to improve the specificity of neuromodulation targeting of the ACC.Entities:
Keywords: ACC; high definition; inhibitory control; tACS; theta frequency; transcranial alternating current stimulation
Year: 2021 PMID: 33859554 PMCID: PMC8042221 DOI: 10.3389/fnsys.2021.611507
Source DB: PubMed Journal: Front Syst Neurosci ISSN: 1662-5137
FIGURE 1Flow chart of the protocol. (A) Schematic overview of the study. (B) Illustration of head modeling with tissue segmentation, co-registration of an individual head model with GPS electrode positioning, and setting of a protocol to select the appropriate electrodes according to the individual cortical current density, followed by neuromodulation protocol settings. (C) Experimental procedure. A double-blind, cross-over study. Three neuromodulation sessions were carried out in random order with a minimum 1 week washout period. The psychometric measurement was tested immediately before and after the end of each neuromodulation session. Types of HD θ-tACS protocols: an individualized HD θ-tACS was targeted with the highest specificity to the mPFC-ACC; a non-individualized θ-tACS was targeted over the MFC with fixed electrode positions in the FCz and Pz areas; a sham tACS was administered with identical electrode montage (as used in the non-individualized protocol). Active θ-tACS sessions comprised a 5 s ramp up, 30 min of 6 Hz θ-tACS, and a 5 s ramp down. Sham condition comprised a 5 s ramp up and 30 s of 6 Hz θ-tACS followed by a 29 min 30 s rest period and a 5 s ramp down. Psychometric measurement was assessed by the Simon Task, Stop Signal Task, Conners’ Continuous Performance Test 3rd edition (CPT III), and the Stroop Test.
The specification of electrode layouts (256-channel HydroCel Geodesic Sensor Net), including the number of electrodes, their position, and current intensity in each electrode used for individualized HD θ-tACS in subjects.
| 1 | 2 | 6 | 10 | 16 | 20; 21 (Fz); 26; 27 | 14; 22 | 124; 125; 137 | 15 | 5; 6; 13; 23;28; 29 |
| 2 | 2 | 6 | 10 | 16 | 20; 21 (Fz); 26; 27 | 14; 22 | 124; 125; 137 | 15 | 5; 6; 13; 23;28; 29 |
| 3 | 2 | 6 | 10 | 16 | 20; 21 (Fz); 26; 27 | 14; 22 | 124; 125; 137 | 15 | 5; 6; 13; 23;28; 29 |
| 4 | 1 | 6 | 10 | 16 | 20; 21 (Fz); 26; 27 | 14; 22 | 124; 125; 137 | 15 | 5; 6; 13; 23;28; 29 |
| 5 | 2 | 6 | 10 | 16 | 20; 21 (Fz); 26; 27 | 14; 22 | 124; 125; 137 | 15 | 5; 6; 13; 23;28; 29 |
| 6 | 2 | 6 | 10 | 16 | 20; 21 (Fz); 26; 27 | 14; 22 | 124; 125; 137 | 15 | 5; 6; 13; 23;28; 29 |
| 7 | 1 | 6 | 10 | 16 | 20; 21 (Fz); 26; 27 | 14; 22 | 124; 125; 137 | 15 | 5; 6; 13; 23;28; 29 |
| 8 | 2 | 5 | 8 | 13 | 21; 26; 27; 28; 33 | 117; 125; 126 (Oz) | 16; 70; 182 | 22; 32; | |
| 9 | 1 | 6 | 10 | 16 | 20; 21 (Fz); 26; 27 | 14; 22 | 124; 125; 137 | 15 | 5; 6; 13; 23;28; 29 |
| 10 | 1 | 5 | 6 | 11 | 20; 26; 27; 31 (NAS) | 25; 32 | 15; 64; 81; 180 | 126 (Oz); 138; 139 | |
| 11 | 2 | 5 | 10 | 15 | 20; 21 (Fz); 26; 27 | 14; 22 | 124; 125; 137 | 15 | 5; 6; 13; 23;28; 29 |
| 12 | 1 | 6 | 10 | 16 | 20; 21 (Fz); 26; 27 | 14; 22 | 124; 125; 137 | 15 | 5; 6; 13; 23;28; 29 |
| 13 | 2 | 6 | 10 | 16 | 20; 21 (Fz); 26; 27 | 14; 22 | 124; 125; 137 | 15 | 5; 6; 13; 23;28; 29 |
| 14 | 1 | 6 | 10 | 16 | 20; 21 (Fz); 26; 27 | 14; 22 | 124; 125; 137 | 15 | 5; 6; 13; 23;28; 29 |
| 15 | 2 | 5 | 7 | 12 | 20; 21 (Fz); 26; 27 | 14; 22 | 124; 125; 137 | 15 | 5; 6; 13; 23;28; 29 |
| 16 | 1 | 6 | 6 | 12 | 20; 26; 27; 31 (NAS) | 25; 32 | 15; 64; 81; 180 | 126 (Oz); 138; 139 | |
| 17 | 1 | 5 | 5 | 10 | 19; 20; 21; 25; 26 | 70; 125; 126 (Oz); 138; 179 | |||
| 18 | 1 | 6 | 10 | 16 | 20; 21 (Fz); 26; 27 | 25; 32 | 137; 138; 148; 149 | 13; 14; 22; 28 | |
| 19 | 2 | 5 | 6 | 11 | 20; 26; 27; 31 (NAS) | 25; 32 | 15; 64; 81; 180 | 126 (Oz); 138; 139 | |
| 20 | 1 | 5 | 7 | 12 | 20; 26; 27; 31 (NAS) | 25; 32 | 15; 64; 81; 180 | 126 (Oz); 138; 139 |
FIGURE 2The electrode placement used in the individualized and non-individualized HD θ-tACS protocols. (Top) The individualized placement of electrodes for HD θ-tACS of the ACC targeted through the mPFC-ACC was selected on the basis of a reciprocity-optimized selection of current injection electrodes. Six anode-cathodes (red electrodes) and 10 cathode-anodes (blue electrodes) are shown. Note that to select the optimal electrode arrangement and current injection electrode, the individualized flux pattern with the highest specificity of current flow for a given target region (mPFC-ACC) on the cortical surface model was used. This is an example montage. (Bottom) Non-individualized placement of electrodes in the FCz and Pz areas (Vosskuhl et al., 2015; Fusco et al., 2018) adapted for the HCGSN 100 using the 10-channel mount with five anode-cathodes (red electrodes) in the FCz area and five cathode-anodes (blue electrodes) in the Pz area for a MFC and medial parietal cortex electrode layout. (Left) anterior view without marking the current density; (middle left) sagittal view; (middle right) anterior view; and (right) view from above, with cortex coloring representing the calculated current density on the cortical surface from 0.0 μA/mm2 (black) to 1.0 μA/mm2 (yellow).
FIGURE 3Flow chart of the psychometric measurement. Flow chart of the psychometric measurement. Illustration of the individual assessments performed for the following periods: Visual Simon Task = 5 min, Stop Signal Task = 9 min, Conners’ Continuous Performance Test 3rd edition (CPT III) = 14 min, Stroop test = 3 min.
Post-modulatory effect of High Definition θ-tACS on cognitive performance.
| Visual Simon Task | Time k (ms) | 402.7 (56.0) | 392.5 (61.5) | 416.9 (70.6) | 397.9 (54.5) | 393.9 (65.5) | 389.7 (48.8) | 0.93 | 0.94 | 0.65 |
| Time ink (ms) | 443.6 (71.9) | 423.9 (70.3) | 430.2 (56.0) | 415.9 (61.4) | 424.6 (72.1) | 418.3 (60.7) | 0.94 | 0.66 | 0.92 | |
| Stop Signal Task | Time ns (ms) | 603.1 (173.6) | 578.9 (182.5) | 602.5 (172.6) | 579.3 (182.7) | 550.8 (157.5) | 567.3 (177.2) | 0.99 | 0.82 | 0.66 |
| Time s (ms) | 523.8 (139.5) | 522.1 (173.8) | 531.4 (161.9) | 518.2 (160) | 516.6 (162.8) | 517.2 (163.9) | 0.97 | 0.99 | 0.99 | |
| CPT III | Commissions | 50.6 (9.9) | 51.6 (10.3) | 49.4 (9.9) | 51.5 (11.5) | 49.3 (9.4) | 50.2 (10.0) | 0.94 | 0.99 | 0.81 |
| Perseverations | 46.3 (1.4) | 47.7 (4.5) | 46.6 (1.9) | 47.5 (4.5) | 46.2 (1.4) | 48.4 (4.1) | 0.86 | 0.59 | 0.32 | |
| HRT (ms) | 374.1 (31.6) | 367.7 (28.0) | 376.9 (32.7) | 373.0 (33.9) | 377.0 (29.8) | 369.6 (29.0) | 0.53 | 0.89 | 0.45 | |
| HRT BC (ms) | 1.5 (4.6) | 1.9 (3.9) | 0.01 (5.3) | 2.1 (4.0) | −0.5 (4.5) | 0.2 (3.7) | 0.96 | 0.96 | 0.74 | |
| Detectability | 45.6 (6.8) | 47.2 (8.4) | 44.5 (6.9) | 47.2 (8.8) | 44.4 (7.1) | 46.3 (8.0) | 0.95 | 1.00 | 0.97 | |
| Stroop | C | 84.8 (11.6) | 86.2 (12.6) | 83.8 (12.6) | 86.2 (10.7) | 83.1 (13.4) | 86.0 (11.2) | 0.52 | 0.41 | 0.36 |
| CW | 55.6 (12.1) | 59.7 (12.6) | 587 (11.7) | 59.4 (11.7) | 59.1 (13.7) | 62.8 (13.2) | 0.02 | 0.50 | 0.13 | |
| IG | 8.5 (9.2) | 13.0 (12.2) | 12.2 (8.0) | 12.3 (10.0) | 13.1 (9.7) | 14.9 (10.3) | 0.01 | 0.26 | 0.39 | |
FIGURE 4Post-modulation changes in the Stroop task after HD θ-tACS. Post-pretest change in the Stroop task represented by the black (W) and colored ink (C) congruous conditions, by the incongruous color-word condition (CW), and by the interference score (IG). The data are presented as mean ± SE. ∗p < 0.05 and ∗∗p<0.01 after Sidak’s correction, linear mixed-effects model.
Adverse or side effects, including bodily sensations and mood state changes induced by θ-tACS.
| Adverse or side post-modulation effects | Mild Headache | 1 | 2 | 0 | 0.22 |
| Irritability | 1 | 9 | 0 | <0.001 | |
| Harmonization or Calm | 8 | 1 | 0 | 0.001 | |
| Increase of Energy | 0 | 3 | 0 | 0.05 | |
| Fatigue | 1 | 0 | 0 | 0.37 | |
| Tingling or burning during tACS | 15 | 15 | 14 | 0.37 | |
| Phosphenes during tACS | 3 | 2 | 0 | 0.25 | |